According to the findings, these changes occurred at least seven years before amyloid plaques became visible on scans. The ...
Grey Matters Health takes delivery of first brain-dedicated PET scanner for Florida clinic Proactive uses images sourced from Shutterstock Grey Matters Health (CSE:GREY, OTCQB:AGNPD, FRA:AGW0) ...
VANCOUVER, British Columbia, March 23, 2026 (GLOBE NEWSWIRE)-- Algernon Health Inc. (the "Company" or "Algernon") (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), is pleased to announce that it will be ...
A team of researchers at the USC Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC has identified important differences in how early ...
Can AI bring more order to amyloid scans? In the February 11 Alzheimer’s & Dementia, scientists led by Pierrick Bourgeat at CSIRO Australian eHealth Research Center, Brisbane, and Vincent Doré of ...
The FDA has approved an updated label for Vizamyl (flutemetamol F 18 injection), including quantification which enables a more continuous and objective measure of amyloid in the brain This approval ...
Detailed price information for Grey Matters Health Inc (GREY-CN) from The Globe and Mail including charting and trades.
A specific pattern of brain metabolism visualized with PET imaging can predict which patients are most likely to benefit from Alzheimer's disease therapy. In a retrospective study of patients who ...
Amyvid can now be used to aid in the selection of patients who are indicated for amyloid beta-directed therapy as described in the prescribing information. The Food and Drug Administration (FDA) has ...
Share on Pinterest New research suggests a blood test may identify Alzheimer’s years before it is detectable on scans. Image credit: Sean Locke/Stocksy A study suggests that a blood test measuring the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results